rna
interfer
rnai
play
pivot
role
regul
gene
express
control
cell
develop
differenti
plant
insect
nematod
rnai
also
function
innat
defenc
respons
virus
similarli
accumul
evid
rnai
function
antivir
defenc
mechan
mammalian
cell
virus
evolv
highli
sophist
mechan
interact
host
cell
machineri
recent
evid
indic
also
involv
rnai
pathway
cellular
rnai
machineri
inhibit
viru
replic
virus
may
also
exploit
rnai
machineri
replic
addit
virus
encod
protein
rna
molecul
suppress
exist
rnai
pathway
trigger
silenc
specif
host
gene
besid
natur
interplay
rnai
virus
induc
rnai
provid
attract
therapi
approach
fight
human
pathogen
virus
summar
latest
news
virusrnai
interact
rnai
base
antivir
therapi
rnai
strongli
conserv
sequencespecif
gene
silenc
mechan
eukaryot
cell
induc
doublestrand
rna
dsrna
current
rnai
shown
function
two
distinct
process
first
regul
cellular
gene
express
via
microrna
mirna
mirna
repres
famili
highli
structur
small
noncod
rna
neg
regul
gene
express
posttranscript
level
express
primari
mirna
primirna
process
protein
drosha
dicer
respect
nucleotid
stemloop
precursor
mirna
premirna
matur
mirna
nt
one
strand
matur
mirna
guid
strand
load
rna
induc
silenc
complex
risc
guid
strand
target
risc
mrna
complex
hybridis
partial
complementari
sequenc
result
mrna
cleavag
translat
inhibit
fig
left
panel
second
function
rnai
inhibit
incom
virus
silenc
transpos
element
gener
small
interf
rna
sirna
nt
dsrna
fig
right
panel
sirna
origin
extens
secondari
rna
structur
viral
rna
dsrna
viral
replic
intermedi
may
fulli
complementari
viral
mrna
load
risc
sirna
typic
trigger
cleavag
mrna
intriguingli
mirnamedi
gene
regul
antivir
sirna
activ
share
dicer
risc
compon
thu
appear
run
along
similar
pathway
therefor
virus
like
affect
cellular
rnai
process
recent
data
indic
virus
interact
rnai
mechan
variou
way
illustr
genet
variat
among
differ
viru
famili
antivir
rnai
respons
might
repres
gener
phenomenon
counter
respons
virus
evolv
rnai
suppressor
protein
rna
molecul
rnaimodul
activ
distinct
virusrnai
interact
recent
report
inhibit
retroviru
cellular
mirna
contrast
hepat
c
viru
hcv
replic
help
cellular
anoth
exampl
specif
virusrnai
interact
discuss
complex
virushost
interact
addit
address
possibl
rnaibas
antivir
strategi
rnai
function
innat
antivir
defenc
mechan
plant
insect
nematod
hypothesi
anim
possess
similar
mechan
remain
rel
untest
fact
sever
anim
virus
encod
rnai
suppressor
func
perhap
best
evid
rnailik
defenc
viru
infect
come
two
recent
studi
nematod
caenorhabd
elegan
wild
type
rnaidefect
cell
anim
infect
vesicular
stomat
viru
vsv
engin
encod
gfp
fusion
protein
upon
infect
cell
lack
compon
rnai
apparatu
produc
gfp
infecti
particl
control
cell
furthermor
mutant
cell
enhanc
rnai
function
shown
produc
less
gfp
way
demonstr
multipl
gene
requir
rnai
also
requir
resist
vsv
suggest
natur
role
rnai
resist
virus
direct
evid
product
virusspecif
sirna
molecul
dsrna
replic
intermedi
infect
cell
recent
studi
probabl
get
closest
affirm
answer
initi
attempt
clone
viral
encod
sirna
mirna
fail
anoth
group
report
mirna
encod
nef
region
genom
addit
bennass
colleagu
character
sequenc
genom
encod
rare
sirna
precursor
hairpin
structur
compos
base
pair
perfectli
complementari
stem
larg
loop
structur
process
dicer
dicerlik
ribonucleas
function
sirna
target
genom
report
tat
protein
function
rnai
suppressor
protein
block
induc
antivir
rnai
respons
interf
dicer
activ
rnai
suscept
virus
larg
dictat
precis
replic
strategi
exampl
rnai
hepat
delta
viru
hdv
success
mrna
molecul
genom
antigenom
rna
sequenc
latter
two
rna
molecul
may
resist
locat
within
nucleu
make
inaccess
cytoplasm
risc
similar
find
report
influenza
viru
respiratori
syncyti
viru
rsv
genom
antigenom
rna
duplex
hdv
also
resist
dicer
cleavag
appear
caus
extend
natur
imperfect
rna
duplex
like
divers
viral
escap
mechan
identifi
near
futur
antivir
rnai
respons
believ
trigger
viral
dsrna
molecul
produc
infect
counter
antivir
effect
virus
evolv
strategi
avoid
recognit
rnai
machineri
host
mani
plant
virus
encod
protein
interfer
one
aspect
dicer
action
andor
sirna
target
rnai
suppressor
first
describ
pathogen
factor
target
rnai
machineri
variou
step
along
silenc
pathway
enabl
viru
accumul
higher
titer
recent
rnai
suppressor
also
identifi
sever
import
human
pathogen
virus
exampl
influenza
viru
protein
vaccinia
viru
protein
tat
protein
adenoviru
virusassoci
rna
ii
varnai
ii
shown
exhibit
rnai
suppressor
activ
discoveri
suggest
rnai
function
innat
antivir
defenc
mechan
mammal
similar
describ
plant
insect
mode
action
rnai
suppressor
human
virus
larg
unknown
other
shown
adenoviru
varna
inhibit
rnai
act
decoy
substrat
exportin
involv
transport
premirna
nucleu
cytoplasm
dicer
risc
tat
protein
thought
block
dicer
activ
wherea
influenza
viru
vaccinia
viru
may
sequest
sirna
presenc
viral
suppressor
function
may
consequ
therapeut
rnai
approach
instanc
shrna
therapeut
approach
depend
dicer
process
may
optim
howev
clearli
earli
toss
towel
ring
potent
inhibit
obtain
approach
besid
suffer
antivir
rnai
respons
virus
also
exploit
rnai
control
express
gene
viral
host
origin
first
exampl
recent
provid
epstein
barr
viru
ebv
larg
dna
viru
herp
famili
preferenti
infect
human
b
cell
small
rna
latent
ebvinfect
burkitt
lymphoma
cell
line
clone
origin
two
region
ebv
genom
comput
method
use
identifi
potenti
target
ebvencod
mirna
among
predict
target
regul
cell
prolifer
apoptosi
transcript
regul
compon
signal
transduct
pathway
although
target
verifi
experiment
strike
sever
gene
one
bind
site
particular
ebvmirna
degrad
cellular
dna
polymeras
demonstr
experiment
furthermor
express
ebvmirna
shown
differ
lytic
versu
latent
stage
suggest
tight
regul
viral
infect
intriguingli
viral
mirna
could
involv
tumour
format
may
explain
ebv
hide
well
member
herpesviru
famili
virus
larg
dna
genom
could
encod
mirna
order
exploit
rnai
regul
host
viral
express
extens
cdna
clone
studi
across
mani
famili
rna
virus
fail
identifi
mirna
virus
rna
genom
date
two
member
cherp
viru
subfamili
kaposi
sarcomaassoci
viru
kshv
murin
gammaherpesviru
one
bherp
viru
cytomegaloviru
cmv
shown
encod
mirna
kshv
encod
array
distinct
mirna
appear
singl
genet
locu
mirna
express
readili
detect
level
copi
per
cell
latent
infect
cell
comput
analysi
potenti
mrna
target
identifi
number
interest
candid
gene
includ
sever
mrna
previous
shown
downregul
kshvinfect
cell
mirna
fulli
conserv
kshv
isol
present
genom
databas
argu
like
play
key
role
kshv
replic
pathogenesi
appar
restrict
viral
mirna
complex
dna
virus
may
reflect
abil
virus
elegantli
manipul
host
gene
express
rel
strippeddown
dna
rna
virus
except
may
small
polyomaviru
simian
viru
encod
set
mirna
whose
vivo
target
clearli
defin
premirna
part
viral
late
premrna
transcript
cleav
polyadenyl
process
dna
genom
circular
late
gene
sequenc
complet
complementari
earli
mrna
produc
opposit
strand
late
mirna
shown
cleav
earli
mirna
predict
posit
late
time
replic
cycl
thu
reduc
earli
gene
express
possibl
evad
immun
recognit
infect
cell
conserv
viral
mirna
polyomaviru
suggest
import
viru
cellular
mirna
import
regul
cellular
gene
recent
evid
indic
cellular
mirna
also
target
genet
materi
invad
virus
comparison
primat
foami
viru
type
genom
human
mirna
reveal
sever
mirna
could
potenti
block
gene
express
replic
retroviru
one
mirna
knock
viru
nearli
doubl
replic
rate
similar
tat
ta
protein
identifi
rnai
suppressor
protein
requir
block
mirna
attack
viru
ta
suppressor
protein
propos
evolv
respons
inhibit
seemingli
simpl
evolutionari
scenario
would
provid
viral
escap
acquisit
one
pointmut
within
target
sequenc
viral
bet
gene
chang
could
even
neutral
respect
encod
bet
protein
silent
codon
chang
select
escap
rnai
via
rout
describ
retroviru
inhibit
design
shrna
antivir
fact
use
escap
rout
may
suggest
besid
antivir
rnai
pressur
viral
sequenc
also
trigger
antivir
rnai
respons
similar
antivir
rnai
respons
plant
insect
cellular
mirna
usual
act
anneal
noncod
region
mrna
therebi
repress
mrna
translat
surprisingli
jopl
et
al
identifi
liverspecif
mirna
interact
noncod
region
hcv
rna
genom
seem
aid
viru
replic
first
time
mirna
molecul
found
posit
regul
gene
express
human
genom
contain
least
gene
code
mirna
author
chose
look
account
mirna
found
liver
place
hcv
replic
therebi
major
caus
chronic
liver
diseas
inhibit
function
use
antisens
oligonucleotid
result
dramat
decreas
hcv
rna
activ
mutant
hcv
rna
alter
target
sequenc
noncod
region
fail
accumul
importantli
defect
could
restor
ectop
express
mutant
compensatori
mutat
allow
base
pair
mutant
hcv
rna
thu
replic
defect
due
lack
interact
due
rna
misfold
mutat
rna
interact
primarili
influenc
rna
translat
stabil
like
affect
viral
rna
replic
involv
hcv
replic
reminisc
usag
trna
ly
prime
revers
transcript
replic
virus
use
avail
cellular
resourc
replic
howev
involv
hcv
replic
contrast
inhibitori
effect
appar
virus
interact
cellular
rnai
factor
variou
way
possibl
viral
host
cell
mrna
also
posit
affect
mirna
two
plant
mirna
demonstr
interact
noncod
region
respect
target
mrna
yet
observ
anim
mirna
anoth
intrigu
question
natur
function
liver
whether
function
influenc
hcv
infect
result
also
potenti
therapeut
relev
first
knock
liver
might
counteract
infect
hcv
second
antivir
si
shrna
strategi
could
focu
target
noncod
region
target
may
highli
access
like
extrem
conserv
maintain
interact
viral
escap
would
extrem
difficult
thu
allow
develop
durabl
therapi
virus
capabl
exploit
cellular
resourc
replic
frequent
modul
cellular
pathway
optim
replic
becom
increasingli
clear
also
intric
relationship
virus
cellular
rnai
machineri
mention
earlier
mirna
regul
cellular
gene
express
antivir
sirna
activ
appear
run
along
similar
pathway
fig
discuss
exampl
cellular
mirna
inhibit
promot
viru
replic
viral
rnai
suppressor
factor
block
dicer
sirna
function
may
affect
cellular
mirna
function
case
discrimin
sirna
mirna
process
scenario
suppressor
inhibit
antivir
rnai
effect
also
interfer
cellular
mirna
function
suppressor
induc
chang
mirna
matur
indirectli
affect
cellular
gene
express
may
contribut
viral
pathogen
plant
turnip
mosaic
viru
rnai
suppressor
protein
hcpro
block
activ
result
abnorm
plant
develop
human
cell
adenoviru
varnai
shown
interfer
mirna
biogenesi
tat
protein
shown
partial
repress
process
activ
dicer
inde
mirna
express
profil
recent
demonstr
differ
cell
express
compar
control
cell
initi
studi
perform
cell
transfect
molecular
clone
repeat
viru
infect
primari
human
cell
conceiv
downregul
matur
mirna
may
due
dicer
suppress
effect
exert
tat
protein
anoth
intrigu
link
cellular
rnai
machineri
becam
appar
identif
trbp
protein
partner
human
dicer
trbp
previous
identifi
tar
rnabind
protein
two
recent
studi
indic
trbp
compon
requir
risc
assembl
optim
rna
silenc
mediat
sirna
endogen
mirna
trbp
previous
assign
sever
function
includ
inhibit
interferoninduc
ifn
dsrnaregul
protein
kinas
pkr
modul
gene
express
associ
tar
trbpdicer
interact
rais
possibl
crosstalk
rnai
ifnpkr
pathway
normal
virusinfect
cell
interestingli
mani
rnai
suppressor
encod
virus
also
inhibitor
ifninduc
pkr
provid
anoth
overlap
two
pathway
find
trbp
essenti
compon
risc
complex
rais
sever
possibl
scenario
interfer
rnai
pathway
instanc
accumul
rna
tar
motif
virusinfect
cell
may
trigger
deplet
trbp
lead
inactiv
risc
rnai
machineri
could
facilit
gener
suppress
rnai
similar
way
adenoviru
varna
block
dicer
risc
sever
altern
scenario
propos
tar
secondari
structur
resembl
mirna
precursor
rais
possibl
tar
viral
premirna
combin
recent
find
tat
protein
suppressor
rnai
particular
inhibitor
dicer
observ
may
suggest
trbp
could
recruit
dicer
tar
absenc
tat
result
function
destruct
transcript
tat
may
prevent
antivir
action
specul
model
incorpor
fact
trbp
contribut
replic
scenario
obvious
requir
experiment
test
instanc
despit
use
sensit
report
assay
never
obtain
evid
function
dice
tar
cell
haasnoot
berkhout
unpublish
result
first
demonstr
rnaimedi
inhibit
human
pathogen
viru
report
bitko
barik
author
report
inhibit
rsv
replic
vitro
use
nanomolar
concentr
synthet
sirna
target
rna
encod
viral
polymeras
subunit
p
fusion
protein
f
current
mani
studi
describ
rnaimedi
inhibit
larg
varieti
virus
rnaimedi
inhibit
receiv
much
attent
addit
differ
rna
virus
differ
dna
virus
effici
target
rnai
includ
import
human
pathogen
hcv
dengu
den
viru
sever
acut
respiratori
syndrom
sar
coronaviru
polioviru
influenza
viru
hdv
human
rhinoviru
hrv
hepat
b
viru
hbv
herp
simplex
viru
human
papillomaviru
hpv
jc
viru
jcv
ebv
cmv
initi
standard
method
induc
rnai
virus
mammalian
cell
transfect
synthet
sirna
shortli
viral
challeng
current
transient
transfect
plasmid
express
antivir
shrna
also
commonli
use
strategi
result
potent
albeit
temporari
inhibit
viru
replic
order
obtain
longterm
viru
resist
research
turn
combin
rnaigen
therapi
approach
approach
lenti
retroor
adenoassoci
viru
aav
vector
use
stabli
transduc
cell
construct
express
shrna
result
viral
resist
sever
studi
report
sirna
suppress
evid
suggest
genom
rna
present
within
infect
virion
particl
target
destruct
appear
new
viral
transcript
synthes
integr
proviru
effici
target
studi
use
chemic
synthes
sirna
transfect
cell
either
shortli
challeng
despit
transient
natur
transfect
experi
singl
sirna
applic
abl
achiev
rel
longlast
suppress
studi
use
transient
transfect
sirnaexpress
vector
howev
develop
effici
vector
deliveri
system
capabl
mediat
stabl
sirna
express
matur
lymphocyt
progenitor
stem
cell
minim
requir
rnai
use
therapeut
modal
lentivir
vector
pol
iii
express
cassett
effici
mean
deliv
antihiv
sirna
haematopoiet
precursor
cell
recent
report
transduc
human
cell
allow
differenti
vivo
scidhu
thymopoiesi
mous
model
matur
lymphocyt
deriv
model
resist
infect
ex
vivo
two
studi
address
potenc
durabl
antihiv
rnai
approach
boden
et
al
express
shrna
tat
gene
aav
vector
potent
inhibit
score
escap
viru
variant
appear
prolong
cultur
similar
result
describ
da
et
al
use
lentivir
vector
unit
express
sirna
sequenc
nef
gene
latter
studi
describ
seven
independ
escap
variant
combin
result
convincingli
demonstr
inhibit
potent
sequencespecif
also
abl
escap
inhibitori
action
singl
sirna
boden
et
al
describ
singl
revert
point
mutat
target
sequenc
da
et
al
describ
larg
varieti
escap
rout
point
mutat
doubl
point
mutat
partial
complet
delet
target
sequenc
deletionbas
resist
mechan
seem
imposs
case
essenti
gene
critic
sequenc
motif
target
thu
one
preferenti
target
essenti
sequenc
well
conserv
among
isol
interest
target
rel
littl
mutat
freedom
multipl
overlap
read
frame
within
genom
includ
tripl
overlap
tatrevenv
ideal
one
target
one
essenti
wellconserv
viral
sequenc
sirna
combin
therapi
sirct
mimic
success
strategi
combat
multipl
antivir
drug
avoid
evolut
escap
variant
recent
discov
altern
resist
mechan
trigger
mutat
target
sequenc
instead
mutat
flank
sequenc
select
subsequ
shown
induc
conform
chang
within
target
sequenc
protect
risc
attack
find
indic
straightforward
predict
viral
escap
rout
nevertheless
one
could
make
first
estim
chanc
viral
escap
therapeut
set
one
multipl
sirna
assum
essenti
viral
sequenc
target
delet
option
therefor
one
like
two
nucleotid
substitut
requir
per
target
sequenc
obtain
fair
level
resist
assum
mutat
need
obtain
complet
resist
assum
error
rate
revers
transcriptas
polymeras
chanc
viral
escap
singl
replic
cycl
studi
field
drugresist
indic
untreat
hivinfect
individu
contain
effect
viral
popul
size
mean
substitut
alreadi
present
within
viral
popul
start
untreat
patient
moder
viral
load
mean
resist
like
occur
thu
may
inde
import
consid
sirct
four
effect
sirna
chanc
viral
escap
drop
practic
mean
viral
escap
imposs
long
viral
suppress
complet
even
sever
assumpt
wrong
prospect
favour
one
achiev
effect
longterm
viral
suppress
altern
strategi
target
unmut
hostencod
function
import
viral
replic
essenti
surviv
host
cell
virus
oblig
intracellular
parasit
whose
replic
depend
host
interplay
import
consequ
viru
host
rnai
newli
discov
mechan
mirna
effector
molecul
play
pivot
role
regul
mani
gene
especi
node
signal
pathway
involv
process
develop
metabol
apoptosi
age
therefor
come
surpris
virus
also
encod
mirna
addit
hostencod
mirna
report
posit
neg
modul
viral
replic
part
virus
encod
rnai
suppressor
protect
cellular
antivir
rnai
respons
may
also
affect
cellular
gene
express
certain
virus
even
evolv
util
mirna
pathway
advantag
nevertheless
better
understand
virushost
interact
molecular
level
allow
us
develop
effect
durabl
nontox
antivir
therapi
rnaibas
treatment
quickli
move
toward
human
patient
year
offer
first
hint
highli
public
techniqu
work
therapeut
set
companyfund
clinic
trial
macular
degener
way
target
transient
viral
infect
pediatr
respiratori
ill
caus
rsv
suppos
launch
soon
chronic
viral
infect
caus
hcv
follow
